The Joint Commission and Kaiser Permanente announce winner of 2024 Bernard J. Tyson National Award for Excellence in Pursuit of Healthcare Equity
| JYNT Stock | USD 10.63 0.68 6.83% |
Slightly above 55% of Joint Corp's private investors are presently thinking to get in. The analysis of overall sentiment of trading The Joint Corp stock suggests that some investors are interested at this time. Joint Corp's investing sentiment can be driven by a variety of factors including economic data, Joint Corp's earnings reports, geopolitical events, and overall market trends.
Joint |
Award honors Zuckerberg San Francisco General Hospital and Trauma Center for closing disparity in readmission rate for BlackAfrican American patients with heart failure Logo for Bernard J. Tyson National Award for Excellence in Pursuit of Healthcare Equity Award logo OAKBROOK TERRACE, Illinois, Dec. 20, 2024 -- The Joint Commission and Kaiser Permanente today announced Zuckerberg San Francisco General Hospital and Trauma Center as the recipient of the 2024 Bernard J. Tys
Read at finance.yahoo.com
 |
Joint Corp Fundamental Analysis
We analyze Joint Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Joint Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Joint Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Joint Corp is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Joint Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Joint Corp stock to make a market-neutral strategy. Peer analysis of Joint Corp could also be used in its relative valuation, which is a method of valuing Joint Corp by comparing valuation metrics with similar companies.
Peers
Joint Corp Related Equities
| MODV | ModivCare | 13.41 | ||||
| EHAB | Enhabit | 1.56 | ||||
| PNTG | Pennant | 1.14 | ||||
| SEM | Select Medical | 0.27 | ||||
| CCEL | CryoCell International | 0.14 | ||||
| NHC | National HealthCare | 0.13 | ||||
| ENSG | Ensign | 0.11 | ||||
| EHC | Encompass Health | 0.08 | ||||
| INNV | InnovAge Holding | 0.51 |
Additional Tools for Joint Stock Analysis
When running Joint Corp's price analysis, check to measure Joint Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Joint Corp is operating at the current time. Most of Joint Corp's value examination focuses on studying past and present price action to predict the probability of Joint Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Joint Corp's price. Additionally, you may evaluate how the addition of Joint Corp to your portfolios can decrease your overall portfolio volatility.